Prospective long-term minimal residual disease monitoring using RQ-PCR in RUNX1-RUNX1T1-positive acute myeloid leukemia: results of the French CBF-2006 trial - Willekens, C; Blanchet, O; Renneville, A; French AML Intergroup (Haematologica, 2016)